Get started
Ipsen S.A.Ipsen S.A.Ipsen S.A.

Ipsen S.A.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

IPSEF chart

Upcoming earnings

Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪9.94 B‬USD
Dividend yield (indicated)
1.07%
Price to earnings Ratio (TTM)
13.29
Basic EPS (TTM)
8.61USD
Net income (FY)
‪711.25 M‬USD
Revenue (FY)
‪3.45 B‬USD
Shares float
‪34.73 M‬
Beta (1Y)
0.61

About IPSEN

Sector
Health Technology
CEO
David G. Loew
Headquarters
Boulogne-Billancourt
Website
ipsen.com
Employees (FY)
‪5.33 K‬
Founded
1998
ISIN
FR0010259150
FIGI
BBG000GNP2P2
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of IPSEF is 117.60 USD — it has increased by 6.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ipsen S.A. stocks are traded under the ticker IPSEF.
Ipsen S.A. is going to release the next earnings report on Jul 24, 2024. Keep track of upcoming events with our Earnings Calendar.
IPSEF stock is 6.16% volatile and has beta coefficient of 0.61. Check out the list of the most volatile stocks — is Ipsen S.A. there?
IPSEF earnings for the last quarter are 5.16 USD per share, whereas the estimation was 5.43 USD resulting in a −5.02% surprise. The estimated earnings for the next quarter are 5.77 USD per share. See more details about Ipsen S.A. earnings.
Ipsen S.A. revenue for the last quarter amounts to ‪1.68 B‬ USD despite the estimated figure of ‪1.67 B‬ USD. In the next quarter revenue is expected to reach ‪1.91 B‬ USD.
Yes, you can track Ipsen S.A. financials in yearly and quarterly reports right on TradingView.
IPSEF net income for the last quarter is ‪495.80 M‬ USD, while the quarter before that showed ‪212.91 M‬ USD of net income which accounts for 132.87% change. Track more Ipsen S.A. financial stats to get the full picture.
Today Ipsen S.A. has the market capitalization of ‪9.96 B‬, it has increased by 3.67% over the last week.
Yes, IPSEF dividends are paid annually. The last dividend per share was 1.28 USD. As of today, Dividend Yield (TTM)% is 1.07%. Tracking Ipsen S.A. dividends might help you take more informed decisions.
Ipsen S.A. dividend yield was 1.11% in 2023, and payout ratio reached 15.40%. The year before the numbers were 1.19% and 15.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, IPSEF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ipsen S.A. stock right from TradingView charts — choose your broker and connect to your account.
IPSEF reached its all-time high on May 10, 2018 with the price of 154.00 USD, and its all-time low was 23.60 USD and was reached on Oct 22, 2012.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪5.33 K‬ employees. See our rating of the largest employees — is Ipsen S.A. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ipsen S.A. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ipsen S.A. stock shows the buy signal. See more of Ipsen S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Ipsen S.A. future price: according to them, IPSEF price has a max estimate of 172.70 USD and a min estimate of 118.00 USD. Read a more detailed Ipsen S.A. forecast: see what analysts think of Ipsen S.A. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ipsen S.A. EBITDA is ‪1.43 B‬ USD, and current EBITDA margin is 30.23%. See more stats in Ipsen S.A. financial statements.